| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e70d7a5f797fbde058f3ff4a2a8b502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21afb1754bd2f4cbd692f20aea4ea89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fac2d148f81b55a1fe4018cdf78d50d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88f7318b1a2b8ced30b7da282d734265 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2012-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df97478d79aee8901efd0bf4689ff3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_095579d53a4439e087c5885cf8b022ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf119cde8234e9f4d40b7e6942fb2ab3 |
| publicationDate |
2014-02-20^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014026707-A1 |
| titleOfInvention |
Anti-vaginitis compositions with improved release and adherence |
| abstract |
The present invention relates to a pharmaceutical composition for treatment of vaginitis comprising: at least one active agent effective against Candida spp., Trichomonas vaginalis and/or Gardnerella vaginalis in an extended release form; a poloxamer mixture containing at least two poloxamers; a fatty acid ester derived from a C8 to C22 saturated or unsaturated fatty acid; and a glycol ether. The novel composition herein described is highly bioadhesive with improved retention time specifically in vaginal conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023150345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017120492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108712901-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684567-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111386129-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112957315-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112957315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596601-B2 |
| priorityDate |
2012-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |